Daniel K. Spiegelman, EVP, Chief Financial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 9,828 shares at $124.16 ($1.2M) on 2015-06-01, disclosed to the SEC on 2015-06-03.
Scheduled sale ($1.2M) by EVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.57 | 4,305 | $541K | 44.0% |
| 2 | $126.15 | 1,578 | $199K | 16.2% |
| 3 | $124.16 | 3,945 | $490K | 39.8% |
| Total | $125.10 avg | 9,828 | $1.2M | 100% |
| Filing → |
| MYGN | SELL | 2022-06-06 | $124K | — | Filing → |
| MYGN | SELL | 2021-06-17 | $192K | — | Filing → |
| MYGN | SELL | 2021-06-01 | $414K | — | Filing → |